Gayo, Princess Kylie .

HRN: 21-46-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2022
OXACILLIN 500MG (VIAL)
06/11/2022
06/18/2022
IVT
375mg
Q6
Cellulitis; Sepsis
Waiting Final Action 
06/11/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/11/2022
06/18/2022
IVT
17mg
Q8
Sepsis
Waiting Final Action 
06/11/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2022
06/18/2022
IVT
100mg
Q8
Cellulitis
Waiting Final Action 
06/11/2022
MUPIROCIN 2%, 15G (TUBE)
06/11/2022
06/18/2022
TOPICAL
2%
BID
Cellulitis
Waiting Final Action 
03/09/2023
CEFTRIAXONE 1G (VIAL)
03/09/2023
03/15/2023
IV
1g
OD
PCAP C
Waiting Final Action 
03/12/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/12/2023
03/19/2023
PO
5mL
TID
AGE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: